AU7000896A - Novel peptide compounds and medicinal compositions thereof - Google Patents

Novel peptide compounds and medicinal compositions thereof

Info

Publication number
AU7000896A
AU7000896A AU70008/96A AU7000896A AU7000896A AU 7000896 A AU7000896 A AU 7000896A AU 70008/96 A AU70008/96 A AU 70008/96A AU 7000896 A AU7000896 A AU 7000896A AU 7000896 A AU7000896 A AU 7000896A
Authority
AU
Australia
Prior art keywords
peptide compounds
medicinal compositions
novel peptide
novel
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70008/96A
Inventor
Masaru Kamishohara
Shiro Kataoka
Tsuyoshi Nishitoba
Eiji Sawa
Motoo Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Publication of AU7000896A publication Critical patent/AU7000896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
AU70008/96A 1995-09-19 1996-09-19 Novel peptide compounds and medicinal compositions thereof Abandoned AU7000896A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP24030195 1995-09-19
JP7-240301 1995-12-27
JP7-352038 1995-12-27
JP35203895 1995-12-27
JP8-210528 1996-07-22
JP8210528A JPH11171896A (en) 1995-09-19 1996-07-22 New peptide compound and its pharmaceutical composition
PCT/JP1996/002697 WO1997011091A1 (en) 1995-09-19 1996-09-19 Novel peptide compounds and medicinal compositions thereof

Publications (1)

Publication Number Publication Date
AU7000896A true AU7000896A (en) 1997-04-09

Family

ID=27329133

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70008/96A Abandoned AU7000896A (en) 1995-09-19 1996-09-19 Novel peptide compounds and medicinal compositions thereof

Country Status (3)

Country Link
JP (1) JPH11171896A (en)
AU (1) AU7000896A (en)
WO (1) WO1997011091A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
US5891646A (en) 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US6743630B2 (en) 2002-03-06 2004-06-01 The Trustees Of Columbia University In The City Of New York Method of preparing a protein array based on biochemical protein-protein interaction
EP1951281B1 (en) 2005-10-17 2015-04-15 Sloan Kettering Institute For Cancer Research Wt1 hla class ii-binding peptides and compositions and methods comprising same
US9265816B2 (en) 2006-04-10 2016-02-23 Sloan Kettering Institute For Cancer Research Immunogenic WT-1 peptides and methods of use thereof
HUE040145T2 (en) * 2011-10-26 2019-02-28 Allergan Inc Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators
US20150104413A1 (en) 2012-01-13 2015-04-16 Memorial Sloan Kettering Cancer Center Immunogenic wt-1 peptides and methods of use thereof
HUE052541T2 (en) 2013-01-15 2021-05-28 Memorial Sloan Kettering Cancer Center Immunogenic wt-1 peptides and methods of use thereof
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
EA201790699A1 (en) * 2014-09-26 2017-10-31 Байер Фарма Акциенгезельшафт STABILIZED DERIVATIVES OF ADRENOMEDULLINE AND THEIR APPLICATION

Also Published As

Publication number Publication date
JPH11171896A (en) 1999-06-29
WO1997011091A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
AU6216296A (en) Pharmaceutical compositions
AUPN411195A0 (en) Medicinal composition
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
AU5984296A (en) Quinazolines and pharmaceutical compositions
AU6232096A (en) Aromatic compounds and pharmaceutical compositions containing them
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU6232196A (en) Aromatic compounds and pharmaceutical compositions containing them
AU7590096A (en) Drug composition
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
AU5155096A (en) Pharmaceutical composition
AU5274096A (en) Pharmaceutical compositions
IL114673A0 (en) Pharmaceutical compositions containing protein
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
AU2531295A (en) Pharmaceutical composition
ZA96525B (en) Novel pharmaceutical compositions
AU5384699A (en) Basic peptides and pharmaceutical compositions containing same
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
AU3191597A (en) Novel medicinal compositions of hydropyridines
GB9502695D0 (en) Pharmaceutical composition
AU3710695A (en) Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
AU1427895A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU1195597A (en) Dibenzothiepin derivatives and pharmaceutical compositions
AU7094996A (en) Novel sulfonamide compounds and medicinal composition